Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07835243 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study to Assess the Effect of Subcutaneous Injection Site on the Pharmacokinetics of Pegozafermin in Healthy Participants

Name: A Study to Assess the Effect of Subcutaneous Injection Site on the Pharmacokinetics of Pegozafermin in Healthy Participants — clinical trial record (NCT07835243)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusNot Yet Recruiting

PhasePhase 1

SponsorHoffmann-La Roche

Started2026-10-07

View on ClinicalTrials.gov ↗

Roche/Genentech

364 trials monitored

See 34 trials at risk

The purpose of this study is to evaluate the pharmacokinetics (PK) of a single subcutaneous (SC) dose of pegozafermin administered in the abdomen, thigh, or upper arm in healthy participants.

Trial Details

NCT Number	NCT07835243
Lead Sponsor	Hoffmann-La Roche
Conditions	Healthy Volunteers
Enrollment	105 participants
Start Date	2026-10-07
Primary Completion	2027-03-02 (estimated)
Study Completion	2027-03-02 (estimated)
Updated on ClinicalTrials.gov	2026-09-22